Core Viewpoint - The announcement indicates that Cinda Securities is planning a share swap merger with China International Capital Corporation (CICC) and Dongxing Securities, which involves issuing A-shares to the shareholders of both companies [1] Group 1: Merger Details - Cinda Securities is in discussions to conduct a share swap merger with CICC and Dongxing Securities [1] - The merger will involve CICC issuing A-shares to all A-share shareholders of Dongxing Securities and Cinda Securities [1] - The restructuring process is subject to significant uncertainties [1] Group 2: Stock Suspension - To ensure fair information disclosure and protect investor interests, Cinda Securities' A-shares will continue to be suspended from trading [1] - The suspension is in accordance with the relevant regulations of the Shanghai Stock Exchange to prevent abnormal fluctuations in the company's stock price [1]

| 证券代码 证券简称 停复牌类型 停牌起始日 停牌期间 停牌终止日 复牌日 | | --- | | ୧01992 中金公司 A 股 停牌 2025/11/20 | 11月26日，中金公司发布公告称，公司与东兴证券股份有限公司、信达证券股份有限公司正在筹划由公司通过向东兴证券全体A股换股股东发行A股股 票、向信达证券全体A股换股股东发行A股股票的方式换股吸收合并东兴证券、信达证券。 鉴于本次重组相关事项存在重大不确定性，为保证信息公平披露，维护投资者利益，避免造成公司股价异常波动，根据上海证券交易所相关规定，公司A 股股票将继续停牌。停牌期间，公司将积极推进各项工作，并根据本次重组进展情况，严格按照有关法律法规的规定和要求履行信息披露义务。 此前的公告显示， 中金公司 A股股票于11月20日起停牌，预计停牌时间不超过25个交易日。 编辑 ｜ 钉钉 ...

Core Viewpoint - The announcement from Yirui Biotechnology (300942.SZ) reveals plans for share reduction by its controlling shareholder and associated parties, indicating a potential liquidity event without significant impact on the company's governance or control structure [1][2]. Share Reduction Plan - Yirui (Hainan) Venture Capital Co., Ltd. plans to reduce its holdings by up to 11,521,758 shares, representing 2.84% of the total share capital, while associated entities plan to reduce their holdings by 288,500 shares (0.07%) and 341,800 shares (0.08%) respectively, totaling a maximum reduction of 12,152,058 shares or 3% of the total [1][2]. - The estimated cash proceeds from the planned share reduction amount to approximately 127.6 million yuan based on the last closing price of 10.50 yuan per share [1]. Current Shareholding Structure - As of the announcement date, Yirui Venture Capital holds 132,369,971 shares (32.68%), Yida Rui holds 19,008,003 shares (4.69%), and Yikai Rui holds 22,577,203 shares (5.57%) [2]. Previous Share Reduction Activities - Recent share reductions included Yirui Venture Capital selling 3,531,208 shares at an average price of 10.66 yuan per share, and the actual controller Zhu Hai reducing his holdings through various transactions, totaling approximately 125 million yuan from July to September 2025 [3]. Fundraising and Financial Performance - Yirui Biotechnology raised a total of 5.45 billion yuan from two fundraising events, with net profits for the years 2021 to 2024 showing fluctuations, including a loss of approximately 184.9 million yuan in 2023 [4][6].

Report Industry Investment Rating No relevant information provided. Core Viewpoints - After the Fed cut interest rates in September, the U.S. Treasury yields have risen for two consecutive weeks. The better - than - expected economic growth and employment data have reduced the need for the Fed to cut interest rates significantly and decreased market expectations for subsequent rate cuts, pushing up the U.S. Treasury yields [1][2]. - The negotiation deadlock between the Republican and Democratic parties over the government financing legislation draft may lead to a U.S. government shutdown in October. However, the market has largely priced in this situation, and the impact on the bond market is expected to be minor [1][3]. - Although the U.S. dollar risk - free rate continued to rise last week, Chinese - funded U.S. dollar bonds were still supported by the narrowing spread and showed general stability. In the on - shore market, due to the approaching National Day holiday and the end of the quarter, the pressure on inter - bank liquidity increased, pushing up short - term interest rates. After the National Day holiday, the pressure on inter - bank funds is expected to ease, which will drive down short - term Treasury yields [1][3][4]. Summary by Related Catalogs Offshore Market - Last week, there were 6 new issuances of Chinese - funded U.S. dollar bonds exceeding $100 million, totaling approximately $1.4 billion, mainly financial bonds and urban investment bonds. Offshore RMB bonds had new issuances of about RMB 61 billion, mainly driven by the issuance of RMB 60 billion central bank bills by the People's Bank of China [2]. - The 10 - year and 2 - year U.S. Treasury yields rose 5 and 7 basis points respectively to 4.18% and 3.64% last week. The U.S. second - quarter real GDP annualized quarterly - on - quarter final value increased by 3.8%, the fastest growth rate in nearly two years. As of the week ending September 20, the number of initial jobless claims in the U.S. decreased by 14,000 to 218,000, the lowest level since July [2]. - The Bloomberg Barclays Chinese - funded U.S. dollar bond total return index fell slightly by 0.1% last week, with the spread narrowing by 2 basis points. Among them, the high - rating index fell 0.1%, and the spread narrowed by 3 basis points; the high - yield index remained flat, and the spread was basically unchanged [3]. On - shore Market - Last week, the People's Bank of China net - withdrew short - term liquidity of RMB 822.3 billion through reverse repurchase maturities and net - injected long - term funds of RMB 30 billion through MLF renewals. The 7 - day deposit - type institutional pledged repurchase weighted average rate and the 7 - day inter - bank pledged repurchase weighted average rate rose 5 and 12 basis points respectively to 1.56% and 1.64%. The 3 - year and 10 - year Treasury yields rose 2 basis points and remained flat respectively at 1.54% and 1.88% [4]. Recent New Issuances of Chinese - funded U.S. dollar Bonds - Newly issued bonds include those from companies such as New Metro Global Limited, Longkou Urban Construction Investment and Development Co., Ltd., and Ping An Insurance Overseas (Holding) Company Limited, with different coupon rates, issuance amounts, and ratings [6]. Appendix: List of Chinese - funded U.S. dollar Bonds - The appendix provides detailed information on a large number of Chinese - funded U.S. dollar bonds, including issuers, guarantors, coupon rates, issuance amounts, prices, ratings, etc. The issuers cover banks, state - owned enterprises, and urban investment companies [18][20].

证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交1.21亿元，其中，买入成交额为4161.81 万元，卖出成交额为7911.32万元，合计净卖出3749.50万元。 具体来看，第一大买入营业部及卖出营业部均为国泰海通证券股份有限公司总部，买入金额为1255.48 万元，卖出金额为3842.55万元。 近半年该股累计上榜龙虎榜5次，上榜次日股价平均跌2.42%，上榜后5日平均跌3.33%。 华新精科(603370)今日上涨0.13%，全天换手率25.83%，成交额4.91亿元，振幅4.91%。龙虎榜数据显 示，营业部席位合计净卖出3749.50万元。 上交所公开信息显示，当日该股因日换手率达25.83%上榜，营业部席位合计净卖出3749.50万元。 华新精科9月19日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 国泰海通证券股份有限公司总部 | 1255.48 | | | 买二 | 高盛(中国)证券有限责任公司上海浦东新区世纪大道证券 | 1094.57 | | | ...

Fundraising Overview - The company has received approval from the China Securities Regulatory Commission for a non-public offering of up to 304,070,293 shares, raising a total of no more than 2,435 million RMB [1] - The actual issuance was 264,673,906 shares at a price of 9.19 RMB per share, with the funds verified by an accounting firm [1] Changes in Fund Usage - The company has decided to change the project "Introduction of 4 A320 aircraft" to "Introduction of 2 A320 aircraft," reallocating the remaining funds to a new project "Introduction of 5 C909 aircraft" [2][3] - The original investment amount for the A320 project was 1,192.10 million RMB, which has been reduced to 754.10 million RMB, with the remaining 438 million RMB redirected to the new C909 project [2] - The project "Purchase of 14 aircraft spare engines" has been terminated, with its funds of 487 million RMB also redirected to the C909 project [2] Tripartite Supervision Agreement - A tripartite supervision agreement has been signed among the company, its wholly-owned subsidiary Yunfei Aircraft Leasing, and the banks involved to ensure proper management of the raised funds [4][6] - The agreement stipulates that the funds for the A320 project must be used solely for that purpose and outlines the responsibilities of each party in monitoring fund usage [4][5] - The new agreement includes provisions for regular checks and balances to protect the interests of small investors [4][5] Supplementary Agreement - A supplementary agreement has been signed to adjust the terms of the original tripartite supervision agreement regarding the new C909 project [6] - The dedicated account for the C909 project has a balance of 4,135,007.78 RMB as of August 7, 2025, and is restricted to the project's funding [6][7]

一心堂药业集团股份有限公司 一心为民 全心服务 股票代码：002727 股票简称：一心堂 公告编号：2025-068 号 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 第 1 页 共 2 页 一心为民 全心服务 本次保荐代表人变更后，公司持续督导期保荐代表人为朱海洲先生和周磊先生。根据《证 券发行上市保荐业务管理办法》《深圳证券交易所上市公司保荐工作指引》等相关规定，持续 督导期至中国证券监督管理委员会和深圳证券交易所规定的持续督导义务结束为止。 公司董事会对于杨志先生在公司2018年度公开发行可转换公司债券持续督导期间所做出的 贡献表示衷心的感谢！ 特此公告。 一心堂药业集团股份有限公司 董事会 一心堂药业集团股份有限公司（以下简称"公司"）于2025年8月11日收到保荐机构东兴证 券股份有限公司（以下简称"东兴证券"）发来的《关于更换持续督导保荐代表人的函》。东 兴证券为公司2018年度公开发行可转换公司债券的保荐机构，截至目前，持续督导期已届满， 但公司募集资金尚未使用完毕，根据相关规定，东兴证券对此次未尽事项继续履行持续督导义 务。 东兴证券原指派的 ...

Core Viewpoint - The company Jiemite (300868.SZ) announced a share reduction plan involving several shareholders, which will not affect the company's control or ongoing operations significantly [1][4][5]. Shareholder Reduction Plans - Shareholder Huang Xin plans to reduce holdings by 1,240,000 shares, representing 0.978% of the total shares after excluding repurchased shares [1][4]. - Shareholder Yang Shaoxu intends to reduce holdings by 415,500 shares, accounting for 0.328% of the total shares after excluding repurchased shares [1][2]. - Other shareholders, including Liu Hui, Li Yun, Bian Erli, Chen Guangping, and Liu Shuwei, also have plans to reduce their holdings, with total planned reductions amounting to 1,905,336 shares, or 1.504% of the total shares [4][5]. Financial Performance - Jiemite's financial performance has shown fluctuations, with net profits for the years 2021 to 2024 being 28.22 million, -116 million, -91.62 million, and 707,000 respectively [7]. - The company's revenue for 2023 was approximately 676.48 million, a decrease of 5.93% from 2022 [8]. - In 2024, the company expects a revenue increase to approximately 761.64 million, reflecting a 12.59% growth compared to 2023 [9]. Company Background - Jiemite was listed on the Shenzhen Stock Exchange on August 24, 2020, with an initial public offering price of 41.26 yuan per share, raising a net amount of approximately 118.97 million yuan [6]. - The company has faced challenges, with its stock currently trading below its initial offering price, indicating a state of underperformance [6].

8月5日，芯动联科大宗交易成交10万股，成交额645万元，占当日总成交额的1.11%，成交价64.5元，较市场收盘价66.15元折价2.49%。 | | 芯动联科 | 688582 | 64.5 દિવેટ | 10 | 东兴证券股份有限 | 海通证券股份有限 | | --- | --- | --- | --- | --- | --- | --- | | | | | | | 公司成都都江堰市 | 公司上海黄浦区合 | | 交易日期 2025-08-05 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | state and State of the may | 卖出营业部 0m 00 3 T | ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 根据万家基金管理有限公司（以下简称"本公司"）分别与中航证券有限公司、民生证券股份有限公司、 中银国际证券股份有限公司、天风证券股份有限公司、上海证券有限责任公司、德邦证券股份有限公 司、东吴证券股份有限公司、东方证券股份有限公司、华鑫证券有限责任公司、华创证券有限责任公 司、申万宏源证券有限公司、申万宏源西部证券有限公司、东兴证券股份有限公司、湘财证券股份有限 公司、第一创业证券股份有限公司、诚通证券股份有限公司以及开源证券股份有限公司（以下合称"上 述机构"）签订的销售协议，本公司自2025年7月28日起新增上述机构办理万家稳康30天持有期债券型证 券投资基金（简称：万家稳康30天持有期债券；基金代码：A类：024530，C类：024531）的销售业 务。万家稳康30天持有期债券自2025年7月28日至2025年8月8日通过基金管理人指定的销售机构公开发 售，投资者可在上述机构办理万家稳康30天持有期债券的开户及认购业务，待基金成立后也可办理申 购、赎回及定投等其他业务，具体费率以上述机构公告为准，具体办理程序请遵循上述机构的相关规 ...